Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.
Cornelis Networks develops networking hardware and software for AI and high-performance computing systems.
xLight to commercialize particle accelerator driven Free Electron Lasers (FEL) for critical US economic and national security applications.
Tamber is an AI "bionic arm" for musicians that enhances creativity with sonic intelligence, real-time sound control & DAW integration.
Xscape Photonics provides photonic chips for high-speed connections in high-performance computing systems and data centers.
Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Open Drives builds network attached, shared storage solution for high resolution image and video workflows.
Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
Swave Photonics is a fabless semiconductor firm that designs and manufactures holographic chips based on diffractive photonics technology.
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
First Ascent Biomedical is a biotechnology company that uses artificial intelligence to design individualized treatment plans.
Graphiant offers Network-as-a-Service solutions for AI, Cloud, and SaaS connectivity.
PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.
SixMap is an information technology company that offers attack surface management solutions to protect government and corporate enterprises.
Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.
T-robotics is a robot software company that uses the inference power to detect and execute tasks based on natural language commands
Generative AI for Fraud Detection
GTM intelligence platform that proves marketing’s revenue impact
Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.
Lightsynq develops universal optical quantum interconnects that bridge the gap to large-scale quantum computers.
MIRIS is a developer of an AI video analytics platform that uses computer vision to detect threats, behavior, and automate monitoring.
Leuko Labs develops non-invasive white blood cell monitoring device.
IAG Capital Partners has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IAG Capital Partners's top investment sectors include Information Technology, Software, Biotechnology, Medical, Artificial Intelligence (AI). The firm invests across 49 different industry categories.
Among tracked funding rounds, Cornelis Networks received $205.0M in a Series C round. IAG Capital Partners's total known invested capital is $1.3B.
IAG Capital Partners's average investment size is $21.8M across its portfolio of 60 companies.
Recent IAG Capital Partners portfolio additions include ReEmerge, Cornelis Networks, xLight, Tamber, Xscape Photonics. These companies were founded in 2020 or later.